These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35496328)

  • 61. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)-
    Shawish I; Barakat A; Aldalbahi A; Malebari AM; Nafie MS; Bekhit AA; Albohy A; Khan A; Ul-Haq Z; Haukka M; de la Torre BG; Albericio F; El-Faham A
    ACS Omega; 2022 Jul; 7(28):24858-24870. PubMed ID: 35874229
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.
    Sun S; Zhang J; Wang N; Kong X; Fu F; Wang H; Yao J
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29295519
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
    Qin X; Yang L; Liu P; Yang L; Chen L; Hu L; Jiang M
    Bioorg Chem; 2021 May; 110():104743. PubMed ID: 33714020
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity.
    Ahmed NM; Youns MM; Soltan MK; Said AM
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking.
    Eissa IH; Ibrahim MK; Alesawy MS; El-Adl K
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100487. PubMed ID: 35194810
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors.
    Tu Y; OuYang Y; Xu S; Zhu Y; Li G; Sun C; Zheng P; Zhu W
    Bioorg Med Chem; 2016 Apr; 24(7):1495-503. PubMed ID: 26906472
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
    Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
    Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
    Ahmed MF; Belal A
    Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors.
    Ibrahim TS; Malebari AM; Mohamed MFA
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832959
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In Vitro Anticancer Activity Screening of Novel Fused Thiophene Derivatives as VEGFR-2/AKT Dual Inhibitors and Apoptosis Inducers.
    Abdelnaby RM; El-Malah AA; FakhrEldeen RR; Saeed MM; Nadeem RI; Younis NS; Abdel-Rahman HM; El-Dydamony NM
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745619
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers.
    Elzahabi HSA; Nossier ES; Alasfoury RA; El-Manawaty M; Sayed SM; Elkaeed EB; Metwaly AM; Hagras M; Eissa IH
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1053-1076. PubMed ID: 35821615
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer.
    Abdel-Mohsen HT; Abd El-Meguid EA; El Kerdawy AM; Mahmoud AEE; Ali MM
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900340. PubMed ID: 32045054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis, Biological Evaluation, 2D-QSAR, and Molecular Simulation Studies of Dihydropyrimidinone Derivatives as Alkaline Phosphatase Inhibitors.
    Altaf R; Nadeem H; Iqbal MN; Ilyas U; Ashraf Z; Imran M; Muhammad SA
    ACS Omega; 2022 Mar; 7(8):7139-7154. PubMed ID: 35252705
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies.
    Parmar DR; Soni JY; Guduru R; Rayani RH; Kusurkar RV; Vala AG; Talukdar SN; Eissa IH; Metwaly AM; Khalil A; Zunjar V; Battula S
    Bioorg Chem; 2021 Oct; 115():105206. PubMed ID: 34339975
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design, synthesis and anticancer evaluation of new 4-anilinoquinoline-3-carbonitrile derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers.
    Zou M; Li J; Jin B; Wang M; Chen H; Zhang Z; Zhang C; Zhao Z; Zheng L
    Bioorg Chem; 2021 Sep; 114():105200. PubMed ID: 34375195
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
    Chinthala Y; Thakur S; Tirunagari S; Chinde S; Domatti AK; Arigari NK; K V N S S; Alam S; Jonnala KK; Khan F; Tiwari A; Grover P
    Eur J Med Chem; 2015 Mar; 93():564-73. PubMed ID: 25743216
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold.
    Hassan A; Badr M; Abdelhamid D; Hassan HA; Abourehab MAS; Abuo-Rahma GEA
    Bioorg Chem; 2022 Mar; 120():105631. PubMed ID: 35091289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.